UroGen Pharma Ltd. Annual Cost of Revenue in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
UroGen Pharma Ltd. quarterly/annual Cost of Revenue history and growth rate from 2016 to 2023.
  • UroGen Pharma Ltd. Cost of Revenue for the quarter ending September 30, 2024 was $2.45M, a 3.63% increase year-over-year.
  • UroGen Pharma Ltd. Cost of Revenue for the twelve months ending September 30, 2024 was $8.7M, a 6.88% decline year-over-year.
  • UroGen Pharma Ltd. annual Cost of Revenue for 2023 was $9.36M, a 22.3% increase from 2022.
  • UroGen Pharma Ltd. annual Cost of Revenue for 2022 was $7.65M, a 48.4% increase from 2021.
  • UroGen Pharma Ltd. annual Cost of Revenue for 2021 was $5.16M, a 411% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.36M +$1.71M +22.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $7.65M +$2.5M +48.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $5.16M +$4.15M +411% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $1.01M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2018 $1.8M +$1.2M +201% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $600K +$572K +2043% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $28K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.